Haywood Capital Markets analyst Gianluca Tucci reiterated his “Buy” rating and $27.00 price target on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts, Financials TSX:KITS) after the company reported fourth-quarter results that were broadly in line with expectations. KITS posted Q4 revenue of $53.9-million and Adjusted EBITDA of $2.4-million, matching its preannouncement on revenue […]
Beacon Securities analyst Kirk Wilson raised his price target on Dexterra Group (Dexterra Group Stock Quote, Chart, News, Analysts, Financials TSX:DXT) to $14.50 from $12.75 while maintaining a “Buy” rating following fourth-quarter results. Dexterra reported Q4 2025 revenue of $271.0-million, about 4% below Wilson’s estimate, while Adjusted EBITDA of $32.6-million was in line with forecasts. […]
Share
Tweet
Share
